Simon G Thompson Selected Research

Simon G Thompson Research Topics

Disease

13	Coronary Disease (Coronary Heart Disease) 01/2017 - 02/2004
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2005
5	Stroke (Strokes) 05/2010 - 10/2005
3	Inflammation (Inflammations) 01/2019 - 03/2011
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 08/2011
3	Vascular Diseases (Vascular Disease) 07/2011 - 11/2009
3	Abdominal Aortic Aneurysm 07/2010 - 12/2008
3	Ischemic Stroke 05/2010 - 11/2009
2	Rupture 02/2013 - 07/2010
2	Aneurysm (Aneurysms) 07/2010 - 12/2008
1	Hypotension (Low Blood Pressure) 01/2020
1	Shock 01/2018
1	Dyspnea (Shortness of Breath) 11/2017
1	Restless Legs Syndrome (Restless Legs) 11/2017
1	Dizziness (Lightheadedness) 11/2017
1	Psoriatic Arthritis 07/2011
1	Diabetes Mellitus 03/2011
1	Atherosclerotic Plaque (Atheroma) 05/2010
1	Myocardial Infarction 05/2010
1	Psychotic Disorders (Schizoaffective Disorder) 09/2005
1	Heart Failure 02/2005
1	Back Pain (Backache) 01/2005
1	Low Back Pain (Lumbago) 01/2005

Drug/Important Bio-Agent (IBA)

7	HDL CholesterolIBA 01/2020 - 11/2009
7	LipidsIBA 01/2019 - 10/2005
7	C-Reactive ProteinIBA 02/2016 - 01/2010
5	LDL CholesterolIBA 01/2020 - 11/2013
5	Fibrinogen (Factor I)FDA Link 01/2016 - 10/2005
4	CholesterolIBA 01/2020 - 06/2012
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017 - 05/2010
3	Triglycerides (Triacylglycerol)IBA 02/2015 - 11/2009
2	EnzymesIBA 01/2017 - 05/2010
2	oxidized low density lipoproteinIBA 01/2014 - 11/2013
2	Lipoprotein(a)IBA 06/2012 - 07/2009
2	ApolipoproteinsIBA 06/2012 - 11/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 12/2008
1	lipoprotein cholesterolIBA 01/2020
1	vinyltriethoxysilane (VTES)IBA 01/2019
1	Ferritins (Ferritin)IBA 11/2017
1	darapladibIBA 01/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2014
1	Trans Fatty AcidsIBA 03/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2014
1	A-factor (Streptomyces)IBA 02/2013
1	Biomarkers (Surrogate Marker)IBA 10/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2012
1	Insulin-Like Growth Factor Binding Protein 3IBA 08/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2011
1	Carrier Proteins (Binding Protein)IBA 08/2011
1	Glucose (Dextrose)FDA LinkGeneric 03/2011
1	Antihypertensive Agents (Antihypertensives)IBA 07/2010
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2010
1	Therapeutic UsesIBA 05/2010
1	Glycoproteins (Glycoprotein)IBA 07/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2009
1	cyclopropapyrroloindoleIBA 12/2008
1	Illicit Drugs (Recreational Drugs)IBA 09/2005
1	Nebivolol FDA Link 02/2005

Therapy/Procedure

2	Endovascular Aneurysm Repair 05/2010 - 12/2008
1	Resuscitation 01/2018
1	Therapeutics 07/2011
1	Drug Prescriptions 07/2010
1	Exercise Therapy (Therapy, Exercise) 01/2005
1	Secondary Prevention 02/2004